- Report
- September 2023
- 214 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- May 2022
- 228 Pages
Global
From €2505EUR$2,625USD£2,099GBP
€5010EUR$5,250USD£4,198GBP
- Report
- April 2022
- 307 Pages
Global
From €5297EUR$5,550USD£4,438GBP
- Report
- October 2021
- 178 Pages
Global
From €2625EUR$2,750USD£2,199GBP
€5249EUR$5,500USD£4,398GBP
- Report
- June 2023
- 144 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- April 2022
- 148 Pages
Global
From €5249EUR$5,500USD£4,398GBP
- Report
- May 2019
- 148 Pages
Global
From €1312EUR$1,375USD£1,099GBP
€2625EUR$2,750USD£2,199GBP
- Report
- December 2023
- 110 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- September 2023
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- September 2023
- 180 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- January 2024
- 200 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- November 2023
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- November 2023
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- January 2023
- 238 Pages
Global
From €2672EUR$2,800USD£2,239GBP
€3818EUR$4,000USD£3,199GBP
- Report
- August 2024
- 80 Pages
Japan
From €3340EUR$3,500USD£2,799GBP
- Report
- February 2024
- 179 Pages
Global
From €4295EUR$4,500USD£3,598GBP

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more